With the improvement of genotyping technologies and the exponentially growing number of available markers, case-control genome-wide association studies promise to be a key tool for investigation of complex diseases. However new analytical methods have to be developed to face the problems induced by this data scale-up, such as statistical multiple testing, data quality control, biological interpretation and computational tractability. We present a novel method to analyze genome-wide association studies results. The algorithm is based on a Bayesian model that integrates genotyping errors and genomic structure dependencies. Probability values are assigned to genomic regions termed bins, which are defined from a gene-biased partitioning of the genome, and the false-discovery rate is estimated. We have applied this algorithm to data coming from three genome-wide association studies of Multiple Sclerosis. The method practically overcomes the scale-up problems and permits to identify new putative regions statistically associated with the disease.
Author: Nicolas Omont, Serono, Biotech and Beyond

Recent Videos RSS

Add to Favorites


1 Response(s) to this entry
Subscribe to comments with RSS.